Liquid chromatography-electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 811, Issue 2, 2004, Pages 209-215

  Singh, Sonu Sundd ^a   Shah, Hiten ^a   Gupta, Sapna ^a   Jain, Manish ^a   Sharma, Kuldeep ^a   Thakkar, Purav ^a   Shah, Ruchy ^a  

^a Biomedical and DMPK Department   (India)

Author keywords

Bioequivalence; Escitalopram; Validation

Indexed keywords

ETHERS; IONIZATION; MASS SPECTROMETRY;

ELECTROSPRAY; HUMAN PLASMA; ION SIGNALS;

LIQUID CHROMATOGRAPHY;

ACETONITRILE; AMMONIUM ACETATE; DICHLOROMETHANE; ESCITALOPRAM; ETHER; PAROXETINE;

ACCURACY; ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG STABILITY; ELECTROSPRAY MASS SPECTROMETRY; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; LIQUID LIQUID EXTRACTION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE;

EID: 7444233562     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(04)00703-2     Document Type: Article

References (22)

1. W.J. Burke Expert Opin. Investig. Drugs 11 10 2002 1477
2. E. Matsui, M. Hoshino, A. Matsui, and A. Okahira J. Chromatogr. B 668 2 1995 299
3. D. Haupt J. Chromatogr. B 685 2 1996 299
4. O.V. Olesen, and K. Linnet J. Chromatogr. B 675 1 1996 83
5. F.C. Kugelberg, B. Carlsson, J. Ahlner, and F. Bengtsson Chirality 15 7 2003 622
6. L. Kristoffersen, A. Bugge, E. Lundanes, and L. Slordal J. Chromatogr. B 734 2 1999 229
7. B. Carlsson, and B. Norlander J. Chromatogr. B 702 1-2 1997 234
8. J. Macek, P. Ptacek, and J. Klima J. Chromatogr. B 755 1-2 2001 279
9. D. Ohman, B. Carlsson, and B. Norlander J. Chromatogr. B 753 2 2001 365
10. B. Rochat, M. Amey, H. Van Gelderen, B. Testa, and P. Baumann Chirality 7 6 1995 389
11. J. Rampono, J.H. Kristensen, L.P. Hackett, M. Paech, R. Kohan, and K.F. Ilett Br. J. Clin. Pharmacol. 50 3 2002 263
12. E. Oyehaug, E.T. Ostensen, and B. Salvsen J. Chromatogr. 227 1 1982 129
13. L. Dalgaard, and C. Larsen Xenobiotica 29 10 1999 1033
14. Z. Zheng, M. Jamour, and U. Klotz Ther. Drug Monit. 22 2 2000 219
15. M. Kosel, C.B. Eap, M. Amey, and P. Baumann J. Chromatogr. B 719 1-2 1998 234
16. J.P. Foglia, B.G. Pollock, M.A. Kirshner, J. Rosen, R. Sweet, and B. Mulsant Psychopharmacol. Bull. 33 1 1997 109
17. D. Haupt J. Chromatogr. B 685 2 1996 299
18. B. Rochat, M. Amey, and P. Baumann Ther. Drug Monit. 17 3 1995 273
19. P.P. Rop, A. Viala, A. Durand, and T. Conquy J. Chromatogr. 338 1 1985 171
20. Guidance for Industry, Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration Centre for Drug Evaluation and Research (CDER), Centre for Veternary Medicine (CVM), May 2001, BP, Website: http://www.fda.gov/cder/guidance/index.htm.
21. FDA Guidance for Industry, Biaoavaliability Studies for Orally Administered Drug-Products-General Considerations, US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), 2000, Website: http://www.fda.gov/cder/guidance/index.htm.
22. FDA Guidance for Industry, Statistical Approaches to Establishing Bioequivalence, US Department of Health and Human Services, Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), 2001, Website: http://www.fda.gov/cder/guidance/index.htm.